The ART of rationing - The need for a new approach to rationing health interventions

South African Medical Journal

Volumn 93, Issue 1, 2003, Pages 56-60

  Kenyon, Christopher ^a   Skordis, Jolene ^a   Boulle, Andrew ^a   Pillay, Karrisha ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE DISTRIBUTION; HEALTH CARE FINANCING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RIGHTS; MEDICAL DECISION MAKING; POPULATION RESEARCH; POVERTY; PUBLIC HEALTH; RESOURCE ALLOCATION; SOCIOECONOMICS; SOUTH AFRICA; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ATTITUDE TO HEALTH; COMMUNITY HEALTH PLANNING; COST-BENEFIT ANALYSIS; DECISION MAKING, ORGANIZATIONAL; DEVELOPING COUNTRIES; HEALTH CARE RATIONING; HEALTH PRIORITIES; HUMANS; NATIONAL HEALTH PROGRAMS; PATIENT RIGHTS; PUBLIC HEALTH PRACTICE; SOCIAL VALUES; SOUTH AFRICA; WORLD HEALTH;

EID: 0037241806     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. World Health Organisation. Scaling Up Antiretroviral Therapy in Resource Limited Settings: Guidelines for a Public Health Approach. Geneva: WHO, 2002.
2. Hogg RS, Yip B, Chan KJ, et al. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA 2001; 286: 2568-2577.
3. The CASCADE Collaboration. Survival after introduction of ART in people with known duration of HIV-1 infection. Concerted Action on SeroConversion to AIDS and Death in Europe. Lancet 2000; 355: 1158-1159.
4. Lovelife. Impending Catastrophe Revisited: An Update on the HIV/AIDS Epidemic in South Africa. Durban: Henry J Kasier Family Foundation, 2001.
5. Boulle A, Kenyon C, Skordis J, Wood R. Exploring the costs of a limited public sector antiretrovial treatment programme for South Africa. S Afr Med J 2002; 92: 811-817.
6. Berkman A. Confronting global AIDS: prevention and treatment. Am J Public Health 2001; 91: 1348-1349.
7. LoveLife. South African National Youth Survey. Durban: Henry J Kasier Family Foundation, 2001.
8. Stoneburner R, Low-Beer D. Analyses of HIV trend and behavioural data in Uganda, Kenya, Malawi and Zambia: Prevalence declines relate more to reduction in sex partners than condom use. XIII International AIDS Conference, Durban, 9 - 14 July 2000.
9. Sweat M, Gregorich S, Sangiwa G, et al. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet 2000: 356: 113-119.
10. Teixera P. The Brazilian experience in universal access to antiretroviral therapy. Report to the World Health Organisation/World Trade Organisation Secretariat Workshop on Differential Pricing and Financing Drugs, 2001. www.aids.gov.br/politica/exp∪iverapy.htm (accessed 10 Sep 2002).
11. UNAIDS. Brazil: Epidemiological Fact Sheet. Geneva: UNAIDS, 2000.
12. UNAIDS. South Africa: Epidemilogical Fact Sheet. Geneva: UNAIDS, 2000.
13. World Health Organisation. Report on the Global HIV/AIDS Epidemic. Geneva: WHO, 2001.
14. Green A. An Introduction to Health Planning in Developing Countries. Oxford: Oxford University Press, 1999.
15. Hill A. What is the minimum cost of ART? European HIV Conference Athens, 28-31 October 2001.
16. United Nations Development Programme. Human Development Report 1998. New York: Oxford University Press, 1998.
17. Freedberg KA, Losina E, Weinstein MC, et al. The cost effectiveness of combination antiretroviral therapy for HIV disease. N Engl J Med 2001; 344: 824-831.
18. Tengs TO, Adams ME, Pliskin JS, et al. Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal 1995; 15: 369-690.
19. Declaration on the TRIPS agreement and public health. Doha, 4th Ministerial Conference, World Trade Organisation, 14 November 2001. www.wto.org/english/thewtoministmindeclipshtm (accessed 5 Sep 2002).
20. Perez-Casa C, Mace C, Berman D, Double J. Accessing ARV's: Untangling the Web of Price Reductions for Developing Countries. Geneva: Medicins Sans Frontieres, Access to Essential Medicines Campaign, 2001.
21. National Department of Health. An Enhanced Response to HIV/AIDS and Tuberculosis in the Public Health Sector-Key Components and Funding Requirements, 2002/03 - 2004/05. National Department of Health, South Africa, 2001.
22. World Health Organisation. World Health Report 1996, Geneva: WHO, 1996.